- Biocon Biologics has received approval from Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its biosimilar Ustekinumab BS.
- This biosimilar is a substitute for Johnson & …
Easy-to-understand Financial Insights that build Wealth.